Bath & Body Works, Inc. (NYSE:BBWI) Holdings Trimmed by Fund 1 Investments LLC

Fund 1 Investments LLC cut its stake in Bath & Body Works, Inc. (NYSE:BBWI - Free Report) by 98.6% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 2,500 shares of the company's stock after selling 176,018 shares during the period. Fund 1 Investments LLC's holdings in Bath & Body Works were worth $97,000 as of its most recent SEC filing.

Several other large investors also recently bought and sold shares of the stock. SRS Capital Advisors Inc. grew its holdings in Bath & Body Works by 99.7% during the fourth quarter. SRS Capital Advisors Inc. now owns 659 shares of the company's stock worth $26,000 after acquiring an additional 329 shares during the period. Golden State Wealth Management LLC acquired a new position in shares of Bath & Body Works during the 4th quarter worth $26,000. UMB Bank n.a. increased its holdings in shares of Bath & Body Works by 58.8% in the 4th quarter. UMB Bank n.a. now owns 905 shares of the company's stock valued at $35,000 after purchasing an additional 335 shares in the last quarter. Lindbrook Capital LLC increased its holdings in shares of Bath & Body Works by 81.9% in the 4th quarter. Lindbrook Capital LLC now owns 957 shares of the company's stock valued at $37,000 after purchasing an additional 431 shares in the last quarter. Finally, Smartleaf Asset Management LLC lifted its stake in shares of Bath & Body Works by 135.0% in the fourth quarter. Smartleaf Asset Management LLC now owns 1,013 shares of the company's stock valued at $39,000 after purchasing an additional 582 shares during the period. Institutional investors and hedge funds own 95.14% of the company's stock.

Bath & Body Works Price Performance

BBWI traded up $0.25 on Tuesday, reaching $33.68. The company's stock had a trading volume of 3,073,008 shares, compared to its average volume of 4,813,519. The stock has a market cap of $7.17 billion, a price-to-earnings ratio of 8.21, a price-to-earnings-growth ratio of 0.92 and a beta of 1.87. The business's 50 day moving average is $29.81 and its 200 day moving average is $33.86. Bath & Body Works, Inc. has a 1 year low of $24.96 and a 1 year high of $52.99.

Bath & Body Works (NYSE:BBWI - Get Free Report) last posted its quarterly earnings results on Thursday, February 27th. The company reported $2.09 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $2.04 by $0.05. The company had revenue of $2.79 billion for the quarter, compared to the consensus estimate of $2.78 billion. Bath & Body Works had a net margin of 12.43% and a negative return on equity of 44.03%. As a group, research analysts forecast that Bath & Body Works, Inc. will post 3.3 earnings per share for the current fiscal year.

Bath & Body Works announced that its board has approved a share repurchase program on Thursday, February 27th that authorizes the company to buyback $500.00 million in outstanding shares. This buyback authorization authorizes the company to repurchase up to 6.4% of its stock through open market purchases. Stock buyback programs are often a sign that the company's management believes its shares are undervalued.

Analysts Set New Price Targets

Several equities analysts have weighed in on BBWI shares. Raymond James dropped their target price on shares of Bath & Body Works from $46.00 to $37.00 and set an "outperform" rating for the company in a report on Thursday, April 17th. Robert W. Baird lifted their price target on shares of Bath & Body Works from $45.00 to $47.00 and gave the stock an "outperform" rating in a report on Friday, February 28th. Morgan Stanley dropped their target price on Bath & Body Works from $49.00 to $43.00 and set an "overweight" rating for the company in a research note on Tuesday, May 6th. JPMorgan Chase & Co. reduced their target price on Bath & Body Works from $47.00 to $41.00 and set an "overweight" rating on the stock in a research report on Monday, April 14th. Finally, The Goldman Sachs Group lowered their price target on Bath & Body Works from $49.00 to $42.00 and set a "buy" rating for the company in a report on Tuesday, April 22nd. Four research analysts have rated the stock with a hold rating and fourteen have given a buy rating to the company's stock. According to MarketBeat, Bath & Body Works presently has an average rating of "Moderate Buy" and a consensus price target of $41.44.

Bath & Body Works Company Profile

Bath & Body Works, Inc is a specialty retailers and home to America's Favorite Fragrances, offering a breadth of exclusive fragrances for the body and home, including the selling collections for fine fragrance mist, body lotion and body cream, 3-wick candles, home fragrance diffusers and liquid hand soap.